Taiwan Advance Bio-Pharmaceutical Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 24.953 million compared to TWD 26.981 million a year ago. Net loss was TWD 9.861 million compared to TWD 86.144 million a year ago. Basic loss per share was TWD 0.12 compared to TWD 1.2 a year ago.